Diazyme Laboratories, Inc. Acquires Alfa Wassermann Diagnostic Technologies LLC.

Cite

APA MLA Chicago

Diazyme Laboratories, Inc. Acquires Alfa Wassermann Diagnostic Technologies LLC. (2026, October 12). Toronto Star. https://www.thestar.com/globenewswire/diazyme-laboratories-inc-acquires-alfa-wassermann-diagnostic-technologies-llc/article_954dc9f6-8e06-58f5-8936-354b64f772b9.html

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Toronto Star · collected 2026-10-12 · by GlobeNewswire, Inc.

Quick Summary

Diazyme Laboratories, Inc. has acquired Alfa Wassermann Diagnostic Technologies LLC (AWDT) from CARR Biosystems. AWDT, an FDA-registered manufacturer and seller of chemistry systems and reagents based in West Caldwell, New Jersey, will now be integrated into Diazyme’s operations. Dr. Chong Yuan, Managing Director of Diazyme Laboratories, stated that this acquisition enhances Diazyme's customer support network and service excellence. Peter Napoli, CEO of AWDT, noted the synergy between the two companies and their commitment to improving services for customers.

Written by AI on 2026-10-12, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

On October 12, 2026, Diazyme Laboratories, Inc., based in Poway, California, acquired the business of Alfa Wassermann Diagnostic Technologies LLC (AWDT) from CARR Biosystems. Founded in 1960 and headquartered in West Caldwell, New Jersey, AWDT is an FDA-registered manufacturer and seller of chemistry systems and reagents. The acquisition will integrate AWDT’s operations into Diazyme's, enhancing its customer support network across the nation, broadening instrumentation placement, and reinforcing its commitment to service excellence. Dr. Chong Yuan, Managing Director of Diazyme Laboratories, stated that the integration will enable Diazyme to expand access to reliable testing solutions for physicians, veterinarians, researchers, and laboratories. Peter Napoli, CEO of AWDT, noted that joining Diazyme will help provide better services and a wider test menu to customers.

Written for “Diagnostic Technology Acquisition” on 2026-10-30, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Diagnostic Technology Acquisition

Technology · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted

sentences that state something as happening or true

Uncertain

0 of 7 hedged ("reportedly", "may", "according to")

Leaning

not political

takes no side on a contested political question

Publisher signals

64/100

Toronto Star's corrections and hedging, across everything collected from it. Not a measure of accuracy.

Outlets on this story

Technology

Same framing elsewhere

articles that frame the event the way this one does

Analyzed 2026-10-12 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability

Source leaning vs. consistency

Publisher

Toronto Star · 10443 article(s) · 27 correction(s) detected

Running correction rate · 27 correction(s)

2026-10-26

Correction

2026-10-24

Correction

2026-10-22

News Clarification for Oct. 22

2026-10-21

No. 6 Hoosiers try to for rare rebound at Michigan after turning the page on 22-game winning streak

2026-10-19

Driver’s License Suspensions for Court Debt Draw Scrutiny

2026-10-16

Amputations and cancer treatment delays: Lawmakers hear testimony on Mississippi prison healthcare

2026-10-16

UPDATE: Golconda Gold Releases Q3 2026 Production Update at Galaxy

2026-10-08

News Clarification for Oct. 8

2026-10-07

Correction

2026-10-05

Entertainment Correction for Oct. 5

2026-10-03

Tennessee's prisons chief is resigning after failed execution of Christa Pike

2026-09-28

Organizations call for Action to End the Deaths of Indigenous People in Custody

2026-09-27

Police memorial recognizes six officers killed in the line of duty in 2026

2026-09-27

UPDATE: WSP to host Power & Energy-focused investor event virtually only

2026-09-26

News Clarification for Sept. 27

2026-09-26

Former federal public servant seeks better pensions for injured workers

2026-09-25

News Corrections for Sept. 25

2026-09-25

She has not been charged. But the Project South allegations have branded her with a 'scarlet letter'

2026-09-24

Correction

2026-09-23

MULTIMEDIA UPDATE: Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management

2026-09-22

Costa Rican man complained of lack of care for diabetes before his death in ICE custody, family says

2026-09-22

Judges' grilling of accused men leads to sex assault and dangerous driving cases being overturned

2026-09-20

Jura Energy Corporation Provides Clarification Regarding Media Reports Concerning Its Petroleum Rights in Pakistan

2026-09-19

New details emerge about Toronto's guns-for-hire and the 'crash-out mission" that sparked the Project South investigation

2026-09-17

UPDATE: Osisko Critical Minerals Corporation Announces C$100 Million Private Placement of Special Warrants

2026-09-17

Alabama set to execute man for pawn shop killings months after his nitrogen gas execution blocked

2026-09-04

Orca Corrects Q3 Quarterly Dividend Announcement

Who wrote this

No reporter is named on this article, beyond the feed's “GlobeNewswire, Inc.”.

Topics

AWDT Alfa Wassermann Diagnostic Technologies Calif. Diazyme POWAY

Subjects

Diazyme ORG · 5× AWDT ORG · 3× Alfa Wassermann Diagnostic Technologies ORG · 2× Alfa Wassermann Diagnostic Technologies LLC. ORG · 1× CARR Biosystems ORG · 1× Calif. GPE · 1× Diazyme Laboratories, Inc. ORG · 1× FDA ORG · 1× POWAY GPE · 1× West Caldwell GPE · 1×

Narrative

“Alfa Wassermann Diagnostic Technologies strengthens Diazyme’s ability to serve customers through a strong nationwide customer support network, wide instrumentation placement, and a demonstrated commitment to service excellence,” said Dr. Chong Yuan, Managing Director of Diazyme Laboratories.

framing: assertive · carried by 1 article(s) · first seen 2026-10-12

🔮 Founded in 1960 and headquartered in West Caldwell, New Jersey, AWDT’s business will be integrated into Diazyme’s operations.

2026-10-12 · Toronto Star

Diazyme Laboratories, Inc. Acquires Alfa Wassermann Diagnostic Technologies LLC. · assertive framing

Claims (7 extracted, 0 hedged)

Diazyme Laboratories, Inc. announced today that it has acquired the business of Alfa Wassermann Diagnostic Technologies LLC. (AWDT) from CARR Biosystems. asserted

it → announce → Biosystems

AWDT is an FDA registered manufacturer and seller of chemistry systems and reagents. asserted

AWDT → register → systems

Founded in 1960 and headquartered in West Caldwell, New Jersey, AWDT’s business will be integrated into Diazyme’s operations. asserted

business → found → operations

Yuan → strengthen → Laboratories

“Through trusted relationships and highly trained technical-support team, Diazyme will be better positioned to expand access to reliable, accurate testing solutions and support physicians, veterinarians, researchers, and laboratories in making timely, informed decisions.” asserted

Diazyme → trust → decisions

Mr. Peter Napoli, CEO of Alfa Wassermann Diagnostics Technologies, said joining Diazyme is synergistic for Alfa Wassermann, and will help provide better services and test menu to our customers”. asserted

joining → say → customers

Mr. Napoli, will continue to manage Alfa Wassermann Diagnostic Technologies business as part of Diazyme’s management team. asserted

Napoli → continue → team

💬Give feedback

🕘History 🎫Support

Terms · Privacy · beta v2.0.0

Articles to 30 Oct 2026